HealthTech Nexus Closes Seed Round to Accelerate AI Platform Development
Funding will be deployed to expand Bio R&D and RegIntel platform capabilities across China, Japan, and Southeast Asia.
Building AI-powered data platforms that connect R&D, regulatory, manufacturing and commercialization for the global pharma industry
Our Vision
"We believe AI and data technology will fundamentally transform how the life sciences industry operates — accelerating innovation from discovery to market and making healthcare breakthroughs more accessible globally."
Global Biopharma Market (USD)
Core AI Platforms
Key Asian Markets
Partnerships
Faster Regulatory Processing
Life Sciences Digitalization CAGR
Connecting data across the full pharmaceutical lifecycle
AI-powered drug discovery, clinical research data management, and scientific intelligence tools
Cross-border regulatory intelligence and multi-region filing workflow automation
Market access analytics, sales intelligence, and precision commercial strategy tools
Unify research data, accelerate drug discovery with AI-assisted target identification and clinical analytics
Navigate multi-country regulatory landscapes with intelligent filing management and compliance tracking
Data-driven market access, KOL management, and commercial performance analytics
AI Product Suite
Life Sciences Digital Platform Matrix
R&D Data Platform
AI-powered drug discovery, clinical data management, and research intelligence for pharma R&D teams
Regulatory Intelligence
Cross-border regulatory intelligence, multi-region filing automation, and compliance tracking system
Commercial Intelligence
Market access analytics, KOL mapping, sales force effectiveness, and commercial launch intelligence
Powering Pharma Innovation with Enterprise-Grade Intelligence
Intelligence Layer
Domain-specific LLMs and ML models trained on life sciences data — accelerating research, regulatory, and commercial decisions
Data Fabric
Seamlessly connects siloed R&D, regulatory, manufacturing, and commercial data into a unified intelligent platform
Trust Layer
Built-in GxP, 21 CFR Part 11, GDPR/PIPL adherence, and enterprise-grade data security across all regions
Guiding life sciences companies from data fragmentation to unified digital excellence
Integrate fragmented R&D, regulatory, and commercial data into a unified platform
Apply AI to uncover hidden patterns, predict outcomes, and accelerate decision-making
Navigate multi-country regulatory requirements with intelligent automation and real-time tracking
Launch products faster, expand into new markets, and drive commercial growth with data-backed strategies
Funding will be deployed to expand Bio R&D and RegIntel platform capabilities across China, Japan, and Southeast Asia.
The RegIntel platform provides real-time regulatory intelligence for pharma companies navigating NMPA, PMDA, and HSA filings.
Partnership will pilot the Bio R&D data platform for translational research, covering clinical data management and AI-assisted drug target identification.